Cancer "hockey sticking" up in young Canadians since mRNA rollout, Allison Inquiry hears
Kaleidoscope Strategic's Deanna McLeod says Ontario billing data shows metastatic cancers spiking in patients under 50 — right on the timeline of the vaccine rollout — and no one in Canada is investigating why.
Nobody tested whether the novel COVID-19 shots caused cancer and now the data may be starting to answer that question.
That's the warning Deanna McLeod, founder of the medical research firm Kaleidoscope Strategic, brought to Dean Allison's inquiry on Parliament Hill, challenging the manic cling to ‘safe and effective.’
McLeod's firm pulled Ontario physician billing codes — the most reliable real-world signal of what doctors are actually diagnosing — and tracked cancer rates through the pandemic. In 2020, rates cratered as public health shut down screening, biopsies, and MRIs. Sure, that’s predictable, but what happened next wasn't. Instead of a rebound back to baseline, cancer rates have kept climbing since, and when McLeod's team isolated the timeline month by month, the surge in female cancers began in March 2021, precisely as mRNA products rolled out to the general population.
Cross-checked against SEER, the premier U.S. cancer registry, the pattern held: a disproportionate rise in metastatic cancer (defined as advanced disease at diagnosis) concentrated in patients under 50, which is notably a group that almost never presents this way.
McLeod is careful to call it correlation, not proof. But she's not alone in asking the question. Testimony from US cardiologist and internist Dr. Peter McCullough at the inquiry described finding fragments of Pfizer's genetic code embedded within tumor tissue — a bladder cancer in a woman in her 30s, a cardiac tumor that metastasized to the brain of a man who died 170 days after his third dose. Dr. McCullough didn't hesitate to use the word that's been dismissed as fringe internet slang for years: turbo cancer.
TURBO CANCER!
— Tamara Ugolini 🇨🇦 (@TamaraUgo) September 17, 2026
“What is the [Pfizer] vaccine genetic material doing in cancer tumor tissue?” Dr @P_McCulloughMD asks at the @AllisonInquiry
“Cancer is moving far more quickly, presenting at a more severe stage, and being far more fatal than we’ve ever seen before.” pic.twitter.com/0AYTGwXgPz
As McLeod points out, these products were classified as vaccines rather than gene therapies, so they were able to skip oncogenicity testing altogether. The clinical trials were stopped early when the control arms were unblinded a mere two months into the study, and nobody looked for cancer – or other – biomarkers before hundreds of millions of healthy people were injected.
When McLeod says "we can't say it doesn't and we can't say it does" — that's not reassurance. That's an admission that five years later, Health Canada and other international regulators still haven't bothered to find out.
This is exactly why the Allison Inquiry matters, because five years ago, saying any of this out loud got you deplatformed. Today, it's sworn testimony, all because Dean Allison decided Canadians who were injured, and the researchers documenting why, deserved a record instead of a shadowban.
